SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028562
Filing Date
2018-11-08
Accepted
2018-11-08 16:16:52
Documents
58
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q chrs-10q_20180930.htm 10-Q 2016155
2 EX-31.1 chrs-ex311_7.htm EX-31.1 16163
3 EX-31.2 chrs-ex312_8.htm EX-31.2 16299
4 EX-32.1 chrs-ex321_6.htm EX-32.1 10772
  Complete submission text file 0001564590-18-028562.txt   6822527

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT chrs-20180930.xml EX-101.INS 1441777
6 XBRL TAXONOMY EXTENSION SCHEMA chrs-20180930.xsd EX-101.SCH 42538
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE chrs-20180930_cal.xml EX-101.CAL 62472
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE chrs-20180930_def.xml EX-101.DEF 180916
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE chrs-20180930_lab.xml EX-101.LAB 351735
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chrs-20180930_pre.xml EX-101.PRE 297309
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36721 | Film No.: 181169883
SIC: 2836 Biological Products, (No Diagnostic Substances)